<?xml version='1.0' encoding='utf-8'?>
<document id="27555820"><sentence text="Inhibition of P-Glycoprotein and Multidrug Resistance-Associated Protein 2 Regulates the Hepatobiliary Excretion and Plasma Exposure of Thienorphine and Its Glucuronide Conjugate."><entity charOffset="136-148" id="DDI-PubMed.27555820.s1.e0" text="Thienorphine" /></sentence><sentence text="Thienorphine (TNP) is a novel partial opioid agonist that has completed phase II clinical evaluation as a promising drug candidate for the treatment of opioid dependence"><entity charOffset="0-12" id="DDI-PubMed.27555820.s2.e0" text="Thienorphine" /><entity charOffset="14-17" id="DDI-PubMed.27555820.s2.e1" text="TNP" /><pair ddi="false" e1="DDI-PubMed.27555820.s2.e0" e2="DDI-PubMed.27555820.s2.e0" /><pair ddi="false" e1="DDI-PubMed.27555820.s2.e0" e2="DDI-PubMed.27555820.s2.e1" /></sentence><sentence text=" Previous studies have shown that TNP and its glucuronide conjugate (TNP-G) undergo significant bile excretion"><entity charOffset="46-57" id="DDI-PubMed.27555820.s3.e0" text="glucuronide" /><entity charOffset="34-44" id="DDI-PubMed.27555820.s3.e1" text="TNP" /><entity charOffset="69-79" id="DDI-PubMed.27555820.s3.e2" text="TNP" /><pair ddi="false" e1="DDI-PubMed.27555820.s3.e1" e2="DDI-PubMed.27555820.s3.e1" /><pair ddi="false" e1="DDI-PubMed.27555820.s3.e1" e2="DDI-PubMed.27555820.s3.e0" /><pair ddi="false" e1="DDI-PubMed.27555820.s3.e1" e2="DDI-PubMed.27555820.s3.e2" /><pair ddi="false" e1="DDI-PubMed.27555820.s3.e0" e2="DDI-PubMed.27555820.s3.e0" /><pair ddi="false" e1="DDI-PubMed.27555820.s3.e0" e2="DDI-PubMed.27555820.s3.e2" /></sentence><sentence text=" The purpose of this study was to investigate the roles of efflux transporters in regulating biliary excretion and plasma exposure of TNP and TNP-G"><entity charOffset="134-136" id="DDI-PubMed.27555820.s4.e0" text="TNP" /><entity charOffset="142-144" id="DDI-PubMed.27555820.s4.e1" text="TNP" /><pair ddi="false" e1="DDI-PubMed.27555820.s4.e0" e2="DDI-PubMed.27555820.s4.e0" /><pair ddi="false" e1="DDI-PubMed.27555820.s4.e0" e2="DDI-PubMed.27555820.s4.e1" /></sentence><sentence text=" An ATPase assay suggested that TNP and TNP-G were substrates of P-gp and MRP2, respectively"><entity charOffset="32-34" id="DDI-PubMed.27555820.s5.e0" text="TNP" /><entity charOffset="40-42" id="DDI-PubMed.27555820.s5.e1" text="TNP" /><pair ddi="false" e1="DDI-PubMed.27555820.s5.e0" e2="DDI-PubMed.27555820.s5.e0" /><pair ddi="false" e1="DDI-PubMed.27555820.s5.e0" e2="DDI-PubMed.27555820.s5.e1" /></sentence><sentence text=" The in vitro data from rat hepatocytes showed that bile excretion of TNP and TNP-G was regulated by the P-gp and MRP2 modulators"><entity charOffset="70-72" id="DDI-PubMed.27555820.s6.e0" text="TNP" /><entity charOffset="78-80" id="DDI-PubMed.27555820.s6.e1" text="TNP" /><pair ddi="false" e1="DDI-PubMed.27555820.s6.e0" e2="DDI-PubMed.27555820.s6.e0" /><pair ddi="false" e1="DDI-PubMed.27555820.s6.e0" e2="DDI-PubMed.27555820.s6.e1" /></sentence><sentence text=" The accumulation of TNP and TNP-G in HepG2 cells significantly increased by the treatment of mdr1a or MRP2 siRNA for P-gp or MRP2 modulation"><entity charOffset="21-23" id="DDI-PubMed.27555820.s7.e0" text="TNP" /><entity charOffset="29-31" id="DDI-PubMed.27555820.s7.e1" text="TNP" /><pair ddi="false" e1="DDI-PubMed.27555820.s7.e0" e2="DDI-PubMed.27555820.s7.e0" /><pair ddi="false" e1="DDI-PubMed.27555820.s7.e0" e2="DDI-PubMed.27555820.s7.e1" /></sentence><sentence text=" In intact rats, the bile excretion, and pharmacokinetic profiles of TNP and TNP-G were remarkably changed with tariquidar and probenecid pretreatment, respectively"><entity charOffset="69-71" id="DDI-PubMed.27555820.s8.e0" text="TNP" /><entity charOffset="77-79" id="DDI-PubMed.27555820.s8.e1" text="TNP" /><pair ddi="false" e1="DDI-PubMed.27555820.s8.e0" e2="DDI-PubMed.27555820.s8.e0" /><pair ddi="false" e1="DDI-PubMed.27555820.s8.e0" e2="DDI-PubMed.27555820.s8.e1" /></sentence><sentence text=" Tariquidar increased the Cmax and AUC0-t and decreased MRT and T1/2 of TNP, whereas probenecid decreased the plasma exposure of TNP-G and increased its T1/2"><entity charOffset="72-74" id="DDI-PubMed.27555820.s9.e0" text="TNP" /><entity charOffset="129-131" id="DDI-PubMed.27555820.s9.e1" text="TNP" /><pair ddi="false" e1="DDI-PubMed.27555820.s9.e0" e2="DDI-PubMed.27555820.s9.e0" /><pair ddi="false" e1="DDI-PubMed.27555820.s9.e0" e2="DDI-PubMed.27555820.s9.e1" /></sentence><sentence text=" Knockdown P-gp and MRP2 function using siRNA significantly increased the plasma exposure of TNP and TNP-G and reduced their mean retention time in mice"><entity charOffset="93-95" id="DDI-PubMed.27555820.s10.e0" text="TNP" /><entity charOffset="101-103" id="DDI-PubMed.27555820.s10.e1" text="TNP" /><pair ddi="false" e1="DDI-PubMed.27555820.s10.e0" e2="DDI-PubMed.27555820.s10.e0" /><pair ddi="false" e1="DDI-PubMed.27555820.s10.e0" e2="DDI-PubMed.27555820.s10.e1" /></sentence><sentence text=" These results indicated the important roles of P-gp and MRP2 in hepatobiliary excretion and plasma exposure of TNP and TNP-G"><entity charOffset="112-114" id="DDI-PubMed.27555820.s11.e0" text="TNP" /><entity charOffset="120-122" id="DDI-PubMed.27555820.s11.e1" text="TNP" /><pair ddi="false" e1="DDI-PubMed.27555820.s11.e0" e2="DDI-PubMed.27555820.s11.e0" /><pair ddi="false" e1="DDI-PubMed.27555820.s11.e0" e2="DDI-PubMed.27555820.s11.e1" /></sentence><sentence text=" Inhibition of the efflux transporters may affect the pharmacokinetics of TNP and result in a drug-drug interaction between TNP and the concomitant transporter inhibitor or inducer in clinic"><entity charOffset="74-76" id="DDI-PubMed.27555820.s12.e0" text="TNP" /><entity charOffset="124-126" id="DDI-PubMed.27555820.s12.e1" text="TNP" /><pair ddi="false" e1="DDI-PubMed.27555820.s12.e0" e2="DDI-PubMed.27555820.s12.e0" /><pair ddi="false" e1="DDI-PubMed.27555820.s12.e0" e2="DDI-PubMed.27555820.s12.e1" /></sentence><sentence text=" " /></document>